Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Reynolds

Showing results (101-110 of 212) with videos related to

Pageof 22
Sort By:
Scientific Data|March 29, 2017
Transcriptomic profiling of 39 commonly-used neuroblastoma cell linesJo Lynne Harenza, Maura A Diamond, Rebecca N Adams, et al.
BMC Biology|December 24, 2010
The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNAPhilipp Kapranov, Georges St Laurent, Tal Raz, et al.
The Journal of Biological Chemistry|October 22, 2002
Ceramide signaling in fenretinide-induced endothelial cell apoptosisAnat Erdreich-Epstein, Linda B Tran, Nina N Bowman, et al.
Pediatric Blood & Cancer|December 19, 2007
Initial testing (stage 1) of the BH3 mimetic ABT-263 by the pediatric preclinical testing programRichard Lock, Hernan Carol, Peter J Houghton, et al.
Scientific Data|December 6, 2017
Corrigendum: Transcriptomic profiling of 39 commonly-used neuroblastoma cell linesJo Lynne Harenza, Maura A Diamond, Rebecca N Adams, et al.
Pediatric Blood & Cancer|April 11, 2007
Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, E Anders Kolb, et al.
Pediatric Blood & Cancer|February 23, 2008
Initial testing (stage 1) of sunitinib by the pediatric preclinical testing programJohn M Maris, Joshua Courtright, Peter J Houghton, et al.
Experimental Cell Research|April 8, 2015
Preservation of high glycolytic phenotype by establishing new acute lymphoblastic leukemia cell lines at physiologic oxygen concentrationMichael A Sheard, Matthew V Ghent, Daniel J Cabral, et al.
Pediatric Blood & Cancer|July 20, 2007
Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, E Anders Kolb, et al.
Pediatric Blood & Cancer|June 26, 2009
Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing programHernan Carol, Richard Lock, Peter J Houghton, et al.
Pageof 22

Showing results (101-110 of 212) with videos related to

Sort By:
Pageof 22
Scientific Data|March 29, 2017
Transcriptomic profiling of 39 commonly-used neuroblastoma cell linesJo Lynne Harenza, Maura A Diamond, Rebecca N Adams, et al.
BMC Biology|December 24, 2010
The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNAPhilipp Kapranov, Georges St Laurent, Tal Raz, et al.
The Journal of Biological Chemistry|October 22, 2002
Ceramide signaling in fenretinide-induced endothelial cell apoptosisAnat Erdreich-Epstein, Linda B Tran, Nina N Bowman, et al.
Pediatric Blood & Cancer|December 19, 2007
Initial testing (stage 1) of the BH3 mimetic ABT-263 by the pediatric preclinical testing programRichard Lock, Hernan Carol, Peter J Houghton, et al.
Scientific Data|December 6, 2017
Corrigendum: Transcriptomic profiling of 39 commonly-used neuroblastoma cell linesJo Lynne Harenza, Maura A Diamond, Rebecca N Adams, et al.
Pediatric Blood & Cancer|April 11, 2007
Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, E Anders Kolb, et al.
Pediatric Blood & Cancer|February 23, 2008
Initial testing (stage 1) of sunitinib by the pediatric preclinical testing programJohn M Maris, Joshua Courtright, Peter J Houghton, et al.
Experimental Cell Research|April 8, 2015
Preservation of high glycolytic phenotype by establishing new acute lymphoblastic leukemia cell lines at physiologic oxygen concentrationMichael A Sheard, Matthew V Ghent, Daniel J Cabral, et al.
Pediatric Blood & Cancer|July 20, 2007
Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, E Anders Kolb, et al.
Pediatric Blood & Cancer|June 26, 2009
Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing programHernan Carol, Richard Lock, Peter J Houghton, et al.
Pageof 22